BidaskClub upgraded shares of CME Group (NASDAQ:CME) from a hold rating to a buy rating in a report published on Tuesday morning.
Several other research analysts have also issued reports on CME. Zacks Investment Research raised CME Group from a hold rating to a buy rating and set a $164.00 target price on the stock in a research report on Tuesday, January 2nd. Keefe, Bruyette & Woods reaffirmed a hold rating and set a $133.00 target price on shares of CME Group in a research report on Thursday, September 21st. Royal Bank of Canada upped their target price on CME Group from $135.00 to $147.00 and gave the company an outperform rating in a research report on Monday, October 16th. Barclays upped their target price on CME Group from $139.00 to $149.00 and gave the company an overweight rating in a research report on Tuesday, October 10th. Finally, Wells Fargo & Co upped their target price on CME Group from $130.00 to $145.00 and gave the company a market perform rating in a research report on Wednesday, October 4th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. CME Group has an average rating of Buy and an average price target of $144.22.
CME Group (NASDAQ:CME) traded up $0.27 on Tuesday, hitting $152.90. The stock had a trading volume of 1,179,500 shares, compared to its average volume of 1,530,000. The company has a market cap of $52,030.00, a price-to-earnings ratio of 34.67, a price-to-earnings-growth ratio of 2.55 and a beta of 0.72. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group has a 52-week low of $113.90 and a 52-week high of $155.29.
The company also recently declared a dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th will be paid a dividend of $3.50 per share. The ex-dividend date of this dividend is Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s payout ratio is presently 59.86%.
In other CME Group news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total transaction of $722,947.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 2,600 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $139.57, for a total value of $362,882.00. Following the sale, the insider now owns 22,301 shares in the company, valued at approximately $3,112,550.57. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,603 shares of company stock worth $6,250,726. Company insiders own 0.57% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of CME. Fiduciary Trust Co. purchased a new stake in shares of CME Group in the second quarter worth about $105,000. Quadrant Capital Group LLC boosted its stake in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares during the last quarter. Valeo Financial Advisors LLC purchased a new stake in shares of CME Group in the third quarter worth about $124,000. San Francisco Sentry Investment Group CA purchased a new stake in shares of CME Group in the second quarter worth about $129,000. Finally, People s United Financial Inc. boosted its stake in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 82.70% of the company’s stock.
TRADEMARK VIOLATION WARNING: “CME Group (CME) Rating Increased to Buy at BidaskClub” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3133444/cme-group-cme-rating-increased-to-buy-at-bidaskclub.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.